Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IJED Espresso.
van Dooren E, Cofar F, Tokar A, Giordani G, Popp I, Sousa N, Stankov V, Gurel G. van Dooren E, et al. Among authors: popp i. Int J Esthet Dent. 2022 May 25;(2):138-139. Int J Esthet Dent. 2022. PMID: 35586995 No abstract available.
Multidisciplinary design: Creating a common perspective in complex cases.
Cofar F, Barbur I, Giordani G, Giordani M, Popp I, Lascu G, Van Dooren E, Bratu T, Blatz M. Cofar F, et al. Among authors: popp i. J Esthet Restor Dent. 2022 Jan;34(1):244-251. doi: 10.1111/jerd.12878. Epub 2022 Jan 27. J Esthet Restor Dent. 2022. PMID: 35083848
Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas.
Becker AP, Becker V, McElroy J, Webb A, Han C, Guo Y, Bell EH, Fleming J, Popp I, Staszewski O, Prinz M, Otero JJ, Haque SJ, Grosu AL, Chakravarti A. Becker AP, et al. Among authors: popp i. Cancers (Basel). 2024 Apr 16;16(8):1516. doi: 10.3390/cancers16081516. Cancers (Basel). 2024. PMID: 38672598 Free PMC article.
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysis.
Dannehl D, Jakob D, Mergel F, Estler A, Engler T, Volmer L, Frevert ML, Matovina S, Englisch A, Tegeler CM, Rohner A, Seller A, Hahn M, Pfister K, Fink A, Popp I, Lorenz S, Tabatabai G, Juhasz-Böss I, Janni W, Brucker S, Taran FA, Hartkopf A, Schäffler H. Dannehl D, et al. Among authors: popp i. ESMO Open. 2024 Apr 17;9(5):102995. doi: 10.1016/j.esmoop.2024.102995. Online ahead of print. ESMO Open. 2024. PMID: 38636292 Free PMC article.
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials.
Popp I, Vaes RDW, Wieten L, Adebahr S, Hendriks L, Bavafaye Haghighi E, Degens J, Schäfer H, Greil C, Peeters S, Waller CF, Houben R, Niedermann G, Rawluk J, Gkika E, Duyster J, Grosu AL, De Ruysscher D. Popp I, et al. Radiother Oncol. 2024 Jan;190:110048. doi: 10.1016/j.radonc.2023.110048. Epub 2023 Dec 7. Radiother Oncol. 2024. PMID: 38070686
Authors' response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study "The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation".
Rühle A, Zou J, Popp I, Nicolay NH. Rühle A, et al. Among authors: popp i. Eur Arch Otorhinolaryngol. 2023 Jun;280(6):3039-3040. doi: 10.1007/s00405-023-07974-2. Epub 2023 Apr 20. Eur Arch Otorhinolaryngol. 2023. PMID: 37079075 Free PMC article. No abstract available.
Authors' response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study "The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation".
Rühle A, Zou J, Popp I, Nicolay NH. Rühle A, et al. Among authors: popp i. Eur Arch Otorhinolaryngol. 2023 Jun;280(6):3043-3044. doi: 10.1007/s00405-023-07960-8. Epub 2023 Apr 13. Eur Arch Otorhinolaryngol. 2023. PMID: 37052686 Free PMC article. No abstract available.
63 results